Analyst stock forecast
Bicara Therapeutics Inc. Stock Forecast and Analyst Price Target
BCAX analyst target range, upside, consensus rating and coverage count.
Direct answer
Bicara Therapeutics Inc.'s average price target is $31.46.
The target implies +26.8% from the recorded current price, and the consensus rating is none.
The verified range is $16.00 to $46.00, with 13 analysts in the current consensus when available.
Forecast evidence checked August 12, 2026.
Get free Bicara Therapeutics Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $24.82
- Average price target
- $31.46
- High price target
- $46.00
- Low price target
- $16.00
- Target upside
- +26.8%
- Consensus rating
- none
- Analysts
- 13
- Evidence date
- August 12, 2026
- Valid through
- August 19, 2026